Molecular simulations provide insight into SARS-CoV-2 variant RBD interactions with ACE2 and mAbs
Researchers aimed to understand the relationship between the SARS-CoV-2 receptor-binding domain and both human receptors and therapeutic targets.
Stay updated with breaking news from Binding Affinity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers aimed to understand the relationship between the SARS-CoV-2 receptor-binding domain and both human receptors and therapeutic targets.
In a new study, a team of researchers assessed the affinity of the SARS-CoV-2 Omicron variant of concern towards major histocompatibility complex (MHC) binding
In a new study, researchers designed artificial intelligence (AI)-based primers for the SARS-CoV-2 Omicron variant.
A new paper in the journal Molecules describes this in molecular terms, comparing SARS-CoV-2 with an earlier highly pathogenic coronavirus, SARS-CoV.
A recent study discusses the role of lateral flow device testing in potentially improving COVID-19 isolation policies.